Molecular biomarkers predictive of sertraline treatment response in young children with fragile X syndrome

作者: Reem Rafik AlOlaby , Stefan R. Sweha , Marisol Silva , Blythe Durbin-Johnson , Carolyn M. Yrigollen

DOI: 10.1016/J.BRAINDEV.2017.01.012

关键词:

摘要: Objectives Several neurotransmitters involved in brain development are altered fragile X syndrome (FXS), the most common monogenic cause of autism spectrum disorder (ASD). Serotonin plays a vital role synaptogenesis and postnatal development. Deficits serotonin synthesis abnormal neurogenesis were shown young children with autism, suggesting that treating within first years life selective reuptake inhibitor might be effective time. In this study we aimed to identify molecular biomarkers serotonergic pathway could predict response sertraline treatment FXS.

参考文章(46)
Amy Cronister, Silverman, Fragile X Syndrome: Diagnosis, Treatment, And Research Johns Hopkins University Press. ,(1991)
Devin K. Binder, Helen E. Scharfman, Brain-derived Neurotrophic Factor Growth Factors Journal. ,vol. 22, pp. 123- 131 ,(2004) , 10.1080/08977190410001723308
David Mamo, Bruce G Pollock, Arun Tiwari, Philip Gerretsen, Daniel J Müller, The intersection of pharmacology, imaging, and genetics in the development of personalized medicine. Dialogues in clinical neuroscience. ,vol. 11, pp. 363- 376 ,(2009)
Anis Contractor, Vitaly A. Klyachko, Carlos Portera-Cailliau, Altered neuronal and circuit excitability in Fragile X Syndrome Neuron. ,vol. 87, pp. 699- 715 ,(2015) , 10.1016/J.NEURON.2015.06.017
Joan Busner, Steven D Targum, The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont (Pa. : Township)). ,vol. 4, pp. 28- 37 ,(2007)
Myoung-Jin Choi, Rhee-Hun Kang, Se-Won Lim, Kang-Seob Oh, Min-Soo Lee, Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Research. ,vol. 1118, pp. 176- 182 ,(2006) , 10.1016/J.BRAINRES.2006.08.012
Flora Tassone, Lihong Qi, Wenting Zhang, Robin L. Hansen, Isaac N. Pessah, Irva Hertz-Picciotto, MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders. Autism Research. ,vol. 4, pp. 250- 261 ,(2011) , 10.1002/AUR.196
Diane C. Chugani, Otto Muzik, Michael Behen, Robert Rothermel, James J. Janisse, Jennifer Lee, Harry T. Chugani, Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology. ,vol. 45, pp. 287- 295 ,(1999) , 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9
Randi J. Hagerman, Jonathan Polussa, Treatment of the psychiatric problems associated with fragile X syndrome. Current Opinion in Psychiatry. ,vol. 28, pp. 107- 112 ,(2015) , 10.1097/YCO.0000000000000131
RONALD J. STEINGARD, BRIAN ZIMNITZKY, DAVID RAY DeMASO, MARGARET L. BAUMAN, JOHN P. BUCCI, Sertraline Treatment of Transition-Associated Anxiety and Agitation in Children with Autistic Disorder Journal of Child and Adolescent Psychopharmacology. ,vol. 7, pp. 9- 15 ,(1997) , 10.1089/CAP.1997.7.9